Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapy

[1] Bowman TS(2003)Cholesterol and the risk of ischemic stroke Stroke 34 2930-2934

[2] Sesso HD(1989)Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial N Engl J Med 320 904-910

[3] Ma J(1989)Serum cholesterol and hemorrhagic stroke in the Honolulu Heart Program Stroke 20 1460-1465

[4] Iso H(1999)Reduction of stroke incidence after myocardial infarction with pravastatin: The Cholesterol and Recurrent Events (CARE) study. The Care Investigators Circulation 99 216-223

[5] Jacobs DR Jr.(2000)Pravastatin therapy and the risk of stroke N Engl J Med 343 317-326

[6] Wentworth D(2001)Reduction of stroke events with pravastatin: The Prospective Pravastatin Pooling (PPP) Project Circulation 103 387-392

[7] Neaton JD(2002)Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: A Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy Circulation 106 1690-1695

[8] Cohen JD(2003)Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm (ASCOT-LLA): A multicentre randomised controlled trial Lancet 361 1149-1158

[9] Yano K(2004)Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions Lancet 363 757-767

[10] Reed DM(1997)Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials Jama 278 313-321

[1] Bowman TS(2003)Cholesterol and the risk of ischemic stroke Stroke 34 2930-2934

[2] Sesso HD(1989)Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial N Engl J Med 320 904-910

[3] Ma J(1989)Serum cholesterol and hemorrhagic stroke in the Honolulu Heart Program Stroke 20 1460-1465

[4] Iso H(1999)Reduction of stroke incidence after myocardial infarction with pravastatin: The Cholesterol and Recurrent Events (CARE) study. The Care Investigators Circulation 99 216-223

[5] Jacobs DR Jr.(2000)Pravastatin therapy and the risk of stroke N Engl J Med 343 317-326

[6] Wentworth D(2001)Reduction of stroke events with pravastatin: The Prospective Pravastatin Pooling (PPP) Project Circulation 103 387-392

[7] Neaton JD(2002)Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: A Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy Circulation 106 1690-1695

[8] Cohen JD(2003)Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm (ASCOT-LLA): A multicentre randomised controlled trial Lancet 361 1149-1158

[9] Yano K(2004)Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions Lancet 363 757-767

[10] Reed DM(1997)Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials Jama 278 313-321